NCT01499446View on ClinicalTrials.gov

A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.

PHASE2CompletedINTERVENTIONAL
Enrollment

669

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Asthma
Interventions
DRUG

GW685698X (fluticasone furoate) 100mcg Morning

GW685698X inhaled once daily in the morning plus placebo in the evening for 28 days

DRUG

GW685698X (fluticasone furoate) 100mcg Evening

GW685698X inhaled once daily in the evening fplus placebo in the morning for 28 days

DRUG

GW685698X (fluticasone furoate) 250mcg Evening

GW685698X inhaled once daily in the evening plus placebo in the morning for 28 days

DRUG

Placebo

Placebo inhaled twice daily (morning and evening) for 28 days

Trial Locations (64)

1162

GSK Investigational Site, Tallinn

1606

GSK Investigational Site, Sofia

1619

GSK Investigational Site, Sofia

2045

GSK Investigational Site, Törökbálint

5800

GSK Investigational Site, Pleven

7500

GSK Investigational Site, Cape Town

9010

GSK Investigational Site, Varna

9300

GSK Investigational Site, Bloemfontein

10000

GSK Investigational Site, Zagreb

10365

GSK Investigational Site, Berlin

10585

GSK Investigational Site, Berlin

10717

GSK Investigational Site, Berlin

10969

GSK Investigational Site, Berlin

13086

GSK Investigational Site, Berlin

13597

GSK Investigational Site, Berlin

15669

GSK Investigational Site, Athens

GSK Investigational Site, Papagos/Athens

16132

GSK Investigational Site, Genoa

20099

GSK Investigational Site, Sesto San Giovanni (MI)

21000

GSK Investigational Site, Split

21335

GSK Investigational Site, Lüneburg

21502

GSK Investigational Site, Geesthacht

30159

GSK Investigational Site, Hanover

30167

GSK Investigational Site, Hanover

31000

GSK Investigational Site, Osijek

33330

GSK Investigational Site, Gütersloh

34117

GSK Investigational Site, Kassel

35128

GSK Investigational Site, Padua

37012

GSK Investigational Site, Bussolengo (VR)

37269

GSK Investigational Site, Eschwege

44100

GSK Investigational Site, Ferrara

50134

GSK Investigational Site, Florence

51014

GSK Investigational Site, Tartu

56124

GSK Investigational Site, Pisa

60126

GSK Investigational Site, Torrette (AN)

63571

GSK Investigational Site, Gelnhausen

68723

GSK Investigational Site, Schwetzingen

69469

GSK Investigational Site, Weinheim

70000

GSK Investigational Site, Bucharest

80024

GSK Investigational Site, Pärnu

80131

GSK Investigational Site, Napoli

84025

GSK Investigational Site, Eboli (SA)

84126

GSK Investigational Site, Salerno

99084

GSK Investigational Site, Erfurt

115446

GSK Investigational Site, Moscow

115478

GSK Investigational Site, Moscow

197022

GSK Investigational Site, Saint Petersburg

400130

GSK Investigational Site, Volgograd

420015

GSK Investigational Site, Kazan'

7500551

GSK Investigational Site, Santiago

7500691

GSK Investigational Site, Santiago

40110-160

GSK Investigational Site, Porto Alegre

1431/1000

GSK Investigational Site, Sofia

31 025

GSK Investigational Site, Kohtal-Jdrve

09456

GSK Investigational Site, Annaberg

08280

GSK Investigational Site, Aue

115 28

GSK Investigational Site, Athens

06720

GSK Investigational Site, Mexico City

04530

GSK Investigational Site, México

Unknown

GSK Investigational Site, Brasov

050159

GSK Investigational Site, Bucharest

123 182

GSK Investigational Site, Moscow

197 089

GSK Investigational Site, Saint Petersburg

634 050

GSK Investigational Site, Tomsk

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY